given trailing underlying diluted eps was 41c for fy17, web is only trading on a trailing p/e of 25.
i think given their >30% organic cagr in bookings combined with their recent m&a and synergies and strong guidance on more than 3x b2c plus 5x b2b growth, we would have to estimate >20-25% compound annual growth in eps over the next 3 years, which means the p/e will go from 25 to 12 in a couple of years.
i suspect web sp will be over $15 within2 years for patient holders.
Ann: Advance Notice of Half Year Results Briefing, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.67 |
Change
-0.120(2.51%) |
Mkt cap ! $1.687B | |||
| Open | High | Low | Value | Volume |
| $4.75 | $4.75 | $4.67 | $7.395M | 1.575M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7586 | $4.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.67 | 224 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| WEB (ASX) Chart |